English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 11 December 2023, 11:00 JST

Source: Olympus
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years

TOKYO, Dec 11, 2023 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, today announced that it has been selected for inclusion in the 2023 Dow Jones Sustainability World Index (DJSI World) and the 2023 Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), both among the most globally recognized corporate sustainability indices. Olympus has been named to the DJSI World for three consecutive years and DJSI Asia Pacific for five.

The Dow Jones Sustainability Indices (DJSI) are corporate sustainability evaluation indices for environmental, social, and governance (ESG) investment. Jointly developed by S&P Dow Jones Indices and RobecoSAM, the DJSI tracks the financial performances of leading companies according to ESG criteria. These indices are updated annually to include companies with excellent corporate sustainability practices.

In 2023, 321 companies were selected as DJSI World members from approximately 2,500 companies worldwide in 62 industry sectors, and 156 companies were selected as DJSI Asia Pacific members from approximately 600 companies assessed in the region. Olympus is one of only 7 out of 76 companies to have been included in the DJSI World Health Care Equipment & Supplies sector. In addition to "Human Rights," "Health Outcome Contribution," and "Environmental Policy & Management Systems," Olympus was recognized this year with improved scores in the areas of "Talent Attraction & Retention" through enhanced employee support programs, and "Corporate Governance" with an increased ratio of female directors. In addition to the DJSI World and Asia Pacific, Olympus was also named to the FTSE4Good Index Series and FTSE Blossom Japan Index.

Comment from Yasuo Takeuchi, Olympus Director, Representative Executive Officer, and Executive Chairman and ESG Officer:

"Olympus has incorporated the concept of ESG into our corporate strategy toward the realization of Our Purpose of "making people's lives healthier, safer and more fulfilling" and is actively developing various initiatives. We are very pleased to have been selected by DJSI World for the third consecutive year, as we consider this a recognition of our efforts. Olympus will continue to deliver innovations that only we can create and contribute to helping our stakeholders, including our employees, solve challenges."

ESG Initiatives

For more information on Olympus' ESG initiatives, please refer to its Integrated Report 2023 and the Sustainability page on its website.

About Olympus

At Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp.

Media contact:
Airi Yuasa
Tel: +81-70-3923-6064
Mail: Global-Public_Relations@olympus.com 

Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com 

Topic: Press release summary
Source: Olympus

Sectors: Environment, ESG, Daily News, Healthcare & Pharm, Local Biz, MedTech
From the Asia Corporate News Network

Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Olympus Related News
Wednesday, 12 June 2024, 11:00 JST
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
Wednesday, 27 March 2024, 15:00 JST
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
Wednesday, 24 January 2024, 15:00 JST
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
Thursday, 7 December 2023, 11:00 JST
Vesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program
Thursday, 30 November 2023, 11:00 JST
Olympus's Net-Zero Targets Approved by SBTi
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575